Oryzon Genomics SA (ES:ORY) has released an update. Oryzon Genomics has reported a reduction in R&D investments and a slight increase in revenue from its own assets for Q3 2024, despite a net loss of ...

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing technologies, will showcase its expanded portfolio for oncology and infectious disease research at ...

SAN FRANCISCO--(BUSINESS WIRE)--Stanford University and Cofactor Genomics, the company bridging the precision medicine gap, announced today that Stanford will join Cofactor’s PREDAPT (Predicting ...

Patient-centered education and navigation support increase consent rates for genomic testing, aiding integration into cancer care and access to genomics-based trials. The SURGE study underscores the ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today ...

Providence researchers and physicians are harnessing the power of artificial intelligence to find patterns hidden among ...

DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic ...

Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow ...

REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...

Genomics company Illumina (NASDAQ:ILMN) in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year ...

Leading Biospecimen Lifecycle Management Platform and Global CRO Formalize Collaboration Following Successful Pilot MONTREAL and RICHMOND, Va., Feb. 3, 2026 /PRNewswire/ -- Slope, the only end-to-end, ...